Dr. Christine Moore is Global Head and Executive Director, GRACS CMC – Policy at Merck. Christine joined Merck after 11 years in various positions at FDA, including Acting Director of the Office of New Drug Quality Assessment and of the Office of Process and Facilities. Prior to moving into the regulatory CMC area, she spent 10 years at Pfizer and Searle/Pharmacia in API process development, process analytical technologies, scale-up, and tech transfer. Throughout her career, Christine has focused on the development of scientific and regulatory approaches for advancing pharmaceutical manufacturing technologies, modernizing regulatory approaches and progressing international harmonization. She has given over 100 invited and keynote presentations, served on multiple ICH working groups, and is a member of the ISPE Board of Directors. Christine holds a PhD in Chemical Engineering from MIT and a BS in Chemical Engineering from Northwestern University.